NOVO NORDISK A/S |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 864 DKK | -1.73% |
|
+0.73% | +23.76% |
| 10:52am | Biophytis: patent application filed in the field of obesity | CF |
| Apr. 12 | Health Care Falls as Risk Aversion Weighs on Obesity Drug Makers -- Health Care Roundup | DJ |
Chart calendar Novo Nordisk A/S
ae6b1c6f0aab177e0df8.s41ugWb4Tkxk0KvgziifG64p26V6c5ud6NcVe5VMsRc.wusbzgC5IRY2h56L_m2yLN5e7u4pC__7r5ojD6IgnETcwinrP5ICBhSV-g~c32d24ab0c1a6bc5cca8bd469ed09a43
Upcoming events on Novo Nordisk A/S
Past events on Novo Nordisk A/S
| 2024-03-21 | Final dividend |
| 2024-03-21 09:00 am | Annual General Meeting |
| 2024-03-07 03:00 am | Capital Markets Day |
| 2024-02-01 08:15 am | Q4 2023 Earnings Call - London |
| 2024-01-31 07:00 am | Q4 2023 Earnings Call |
| 2024-01-31 01:30 am | Q4 2023 Earnings Release |
| 2024-01-09 12:45 pm | JPMorgan Healthcare Conference |
| 2023-11-11 06:00 pm | R&D Day |
| 2023-11-03 09:15 am | Q3 2023 Earnings Call - London |
| 2023-11-02 08:00 am | Q3 2023 Earnings Call |
| 2023-11-02 02:30 am | Q3 2023 Earnings Release |
| 2023-09-12 | Split: 2 of 1 |
| 2023-08-17 | Ex-dividend day for dividende intermédiaire |
| 2023-08-11 08:15 am | Q2 2023 Earnings Call - London |
| 2023-08-10 07:00 am | Q2 2023 Earnings Call |
| 2023-08-10 01:30 am | Q2 2023 Earnings Release |
| 2023-06-25 10:30 pm | R&D Day |
| 2023-06-25 10:30 pm | American Diabetes Association Scientific Session |
| 2023-05-09 08:15 am | Q1 2023 Earnings Call - London |
| 2023-05-04 07:00 am | Q1 2023 Earnings Call |
Past dividends on Novo Nordisk A/S
| 2024-03-21 | Final Payment 6.4 DKK |
| 2023-08-17 | Interim Payment 6 DKK |
| 2023-03-23 | Final Payment 8.15 DKK |
| 2022-08-11 | Interim Payment 4.25 DKK |
| 2022-03-24 | Final Payment 6.9 DKK |
| 2021-08-15 | Interim Payment 3.5 DKK |
| 2021-03-25 | Final Payment 5.85 DKK |
| 2020-08-13 | Interim Payment 3.25 DKK |
| 2020-03-26 | Final Payment 5.35 DKK |
| 2019-08-15 | Interim Payment 3 DKK |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million DKK | Released Forecast Spread | 122 021 120 928 0.9% | 126 946 126 811 0.11% | 140 800 139 863 0.67% | 176 954 175 090 1.06% | 232 261 228 920 1.46% | 287 347 |
|
EBITDA Million DKK | Released Forecast Spread | 58 144 57 185 1.68% | 59 879 59 490 0.65% | 64 669 65 263 -0.91% | 82 171 82 386 -0.26% | 111 987 109 530 2.24% | 139 525 |
|
EBIT Million DKK | Released Forecast Spread | 52 483 52 535 -0.1% | 54 126 54 325 -0.37% | 58 644 59 273 -1.06% | 74 809 75 141 -0.44% | 102 574 101 255 1.3% | 129 052 |
|
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 48 553 48 568 -0.03% | 53 130 52 821 0.59% | 59 080 59 575 -0.83% | 69 062 69 370 -0.44% | 104 674 102 184 2.44% | 129 963 |
|
Net income Million DKK | Released Forecast Spread | 38 951 38 969 -0.05% | 42 138 42 023 0.27% | 47 757 47 534 0.47% | 55 525 54 785 1.35% | 83 683 82 021 2.03% | 103 704 |
|
EPS DKK | Released Forecast Spread | 8,19 8,18 0.07% | 9,01 9,00 0.02% | 10,4 10,3 0.35% | 12,2 12,2 0.25% | 18,6 18,3 1.79% | 23,2 |
| Announcement Date | 05/02/20 | 03/02/21 | 02/02/22 | 01/02/23 | 31/01/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million DKK | Released Forecast Spread | 38 333 37 744 1.56% | 42 301 39 193 7.93% | 41 265 41 679 -0.99% | 45 566 44 493 2.41% | 48 092 47 116 2.07% | 53 367 52 192 2.25% | 54 300 55 820 -2.72% | 58 731 57 395 2.33% | 65 863 61 207 7.61% | 63 781 | 67 374 | 72 628 | 81 093 | 77 484 |
|
EBITDA Million DKK | Released Forecast Spread | 15 716 15 845 -0.81% | 20 797 18 508 12.37% | 20 027 20 078 -0.25% | 22 225 20 889 6.4% | 19 122 19 770 -3.28% | 26 726 25 825 3.49% | 26 065 26 770 -2.64% | 29 438 27 843 5.73% | 29 758 27 194 9.43% | 31 388 | 33 803 | 36 833 | 38 628 | 37 297 |
|
EBIT Million DKK | Released Forecast Spread | 13 634 14 283 -4.54% | 19 147 17 181 11.44% | 18 391 18 459 -0.37% | 20 184 19 230 4.96% | 17 087 18 221 -6.22% | 25 007 23 950 4.41% | 23 888 25 252 -5.4% | 26 913 25 565 5.27% | 26 766 25 489 5.01% | 28 709 | 30 144 | 33 421 | 35 904 | 35 116 |
|
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | 13 113 13 683 -4.16% | 17 919 16 538 8.35% | 16 795 17 424 -3.61% | 18 032 17 570 2.63% | 16 316 16 547 -1.4% | 24 737 24 538 0.81% | 24 254 26 344 -7.93% | 28 063 26 623 5.41% | 27 620 25 972 6.34% | 28 534 | 30 018 | 33 831 | 36 679 | 35 182 |
|
Net income Million DKK | Released Forecast Spread | 10 892 10 791 0.93% | 14 210 13 110 8.39% | 13 318 13 902 -4.2% | 14 405 14 040 2.6% | 13 592 13 152 3.35% | 19 814 19 606 1.06% | 19 428 20 692 -6.11% | 22 478 21 592 4.1% | 21 963 20 717 6.01% | 23 173 | 24 103 | 26 986 | 28 139 | 27 982 |
|
EPS DKK | Released Forecast Spread | 2,38 2,34 1.72% | 3,11 2,88 8.03% | 2,93 2,99 -2.07% | 3,17 3,11 1.99% | 3,01 2,93 2.74% | 4,39 4,37 0.36% | 4,32 4,62 -6.59% | 5,00 4,50 11.05% | 4,91 4,59 7.08% | 5,18 | 5,40 | 6,03 | 6,28 | 15,0 |
| Announcement Date | 02/02/22 | 29/04/22 | 03/08/22 | 02/11/22 | 01/02/23 | 04/05/23 | 10/08/23 | 02/11/23 | 31/01/24 | - | - | - | - | - |
More events
Past sector events for Novo Nordisk A/S
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NOVO B Stock
- Calendar Novo Nordisk A/S
